Dopamine D5 Receptors: A Challenge to Medicinal Chemists

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|8|10|976-995

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.8, Iss.10, 2008-09, pp. : 976-995

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Due to the lack of highly selective dopamine D1 or D5 receptor ligands, only few data about activation or blocking of these receptor subtypes are available. The present review collects the available information about molecules with notable affinity for D5 receptor subtype with the purpose to help the researchers to design novel D5 selective ligands, whose discovery may enrich the knowledge about the physiological function of such a receptor, provide information about its topography, as well as lead to novel potential therapeutic tools.

Related content

Activation of 5-HT 1B/1D receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study

By Yan Q.-S.   Yan S.-E.  

European Journal of Pharmacology, Vol. 418, Iss. 1, 2001-04 ,pp. : 55-64 (10)

Elsevier

Access to resources Recommend Favorite

Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT1A Receptors as New Antipsychotical or Anti-Parkinsonian Agents

By  

Current Medicinal Chemistry, Vol. 21, Iss. 4, 2014-02 ,pp. : 437-457 (21)

Bentham Science Publishers

Access to resources Recommend Favorite

Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors

By Nagai Taku   Murai Rina   Matsui Kanae   Kamei Hiroyuki   Noda Yukihiro   Furukawa Hiroshi   Nabeshima Toshitaka  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 315-328 (14)

Springer Publishing Company

Access to resources Recommend Favorite

The dopamine D 4 receptors and mechanisms of antipsychotic atypicality

By Wong A.H.C.   Van Tol H.H.M.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 7, 2003-10 ,pp. : 1091-1099 (9)

Elsevier

Access to resources Recommend Favorite

Tetrahydroisoquinololine derivatives as modulators of dopamine D3 receptors

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 985-989 (5)

Informa Healthcare

Access to resources Recommend Favorite